You are here

Coherus Biosciences

Coherus BioSciences Re-Submits BLA for Neulasta (Pegfilgrastim) Biosimilar Candidate

CP Wire

Thu, 05/3/18 - 11:11 pm

Coherus Biosciences

Coherus BioSciences Re-Submits BLA for Neulasta (Pegfilgrastim) Biosimilar Candidate

Thu, 05/3/18 - 02:45 pm

Coherus Biosciences

Key Humira patent gets struck down for the second time in as many months

Fierce Pharma

Sun, 07/9/17 - 11:38 am

Boehringer Ingelheim

Coherus Biosciences

Coherus cuts staff after FDA red light

BioPharma Dive

Wed, 06/28/17 - 10:52 pm

Coherus Biosciences

Amgen loses its bid to delay biosimilars as SCOTUS hands Novartis a victory

Endpoints

Mon, 06/12/17 - 09:24 pm

Coherus Biosciences

American-made biosimilars a differentiator in US market, Coherus

Biopharma Reporter

Fri, 03/17/17 - 09:23 am

Coherus Biosciences

Amgen accuses would-be copycat Coherus of stealing its Neulasta secrets

Fierce Pharma

Tue, 03/7/17 - 11:52 am

Coherus Biosciences

AbbVie: Take That Coherus!

Barron's

Tue, 11/8/16 - 09:58 am

Coherus Biosciences

These 15 Biotech Companies Could Be Takeover Targets

Barron's

Wed, 06/29/16 - 12:56 pm

Alder Biopharmaceuticals

Coherus Biosciences

Intercept Pharma

Seattle Genetics

Adamas Pharmaceuticals

Clovis Oncology

Corbus Pharmaceuticals

Puma Biotechnology

AbbVie Slides as U.S. Agency Questions Humira Patent

Bloomberg

Tue, 05/17/16 - 12:07 pm

Coherus Biosciences

rheumatoid arthritis

Can Humira Still Dominate In 2022?

Seeking Alpha

Thu, 04/21/16 - 03:28 pm

Bristol-Myers Squibb

Coherus Biosciences

Gilead Sciences

Intercept Pharma

Baxalta, Coherus say Enbrel biosimilar succeeds in study

Yahoo/Reuters

Mon, 01/11/16 - 08:36 am

Coherus Biosciences

rheumatoid arthritis

Amgen: Time is on My Side

Barron's

Sat, 09/5/15 - 10:56 am

Coherus Biosciences

Coherus inks $246M Baxter deal to develop Enbrel biosimilar

Fierce Biotech

Tue, 09/3/13 - 11:19 am

Coherus Biosciences

Baxter International

Pages